The Joint Corp. sold 31 clinics for $8.3 million, aiming to enhance business performance by increasing franchisee ownership.
Quiver AI Summary
The Joint Corp. has announced the successful sale of 31 corporate clinics and franchise rights in Arizona and New Mexico to Joint Ventures, LLC for $8.3 million, along with regional developer rights generating $855,000 in royalties over the past year. This refranchising initiative aims to streamline The Joint's operations and enhance performance by entrusting clinics to experienced franchise operators. The deal allows The Joint to acquire additional rights in the Northwest region, covering multiple existing and future clinic sites, which is expected to improve profit margins by reducing commission obligations. The company continues to prioritize creating an improved patient experience while driving growth and increasing shareholder value.
Potential Positives
- Closed the sale of 31 corporate clinics for $8.3 million, enhancing financial liquidity.
- Expansion plans with commitment to open 10 additional clinics, signaling growth potential.
- Acquisition of regional developer rights expected to reduce commission obligations and increase operating margin.
- Strong validation from existing franchisees by increasing their stake, supporting corporate initiatives to enhance patient experience and drive revenue.
Potential Negatives
- The sale of a significant number of corporate owned clinics (31) might indicate difficulties in managing these locations effectively under corporate ownership.
- The reliance on franchising due to a refranchising initiative could signal operational weaknesses or challenges in maintaining corporate clinics profitability.
- Forward-looking statements highlight risks and uncertainties related to staffing challenges and potential increases in operating expenses, which could hurt future financial performance.
FAQ
What recent milestone did The Joint Corp. achieve?
The Joint Corp. has grown to 96 clinics and plans to open 10 additional clinics.
How much was the recent sale of clinics for?
The sale of 31 clinics and franchise licenses was for $8.3 million.
What are the regional developer rights acquired in the sale?
The regional developer rights cover the Northwest region, involving 46 existing clinics and 30 future development sites.
How did the sale impact royalty and commission obligations?
The acquisition of regional developer rights is expected to reduce commission obligations and increase operating margins.
What does The Joint Corp. focus on in its initiatives?
The Joint Corp. aims to enhance patient experience, drive revenue, and reduce operational costs through strategic refranchising.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$JYNT Hedge Fund Activity
We have seen 24 institutional investors add shares of $JYNT stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALTA FOX CAPITAL MANAGEMENT, LLC added 403,096 shares (+inf%) to their portfolio in Q1 2025, for an estimated $5,034,669
- CLAYTON PARTNERS LLC removed 95,000 shares (-30.6%) from their portfolio in Q1 2025, for an estimated $1,186,550
- TOPLINE CAPITAL MANAGEMENT, LLC added 52,956 shares (+16.3%) to their portfolio in Q1 2025, for an estimated $661,420
- GOLDMAN SACHS GROUP INC removed 37,377 shares (-9.9%) from their portfolio in Q1 2025, for an estimated $466,838
- RUSSELL INVESTMENTS GROUP, LTD. added 36,319 shares (+45.0%) to their portfolio in Q1 2025, for an estimated $453,624
- GREENWOOD CAPITAL ASSOCIATES LLC removed 33,621 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $419,926
- FIRST FOUNDATION ADVISORS added 27,444 shares (+21.0%) to their portfolio in Q1 2025, for an estimated $342,775
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
- Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics -
- Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in
Royalties and Franchise Fees over the 12 Months Ended March 31, 2025 -
SCOTTSDALE, Ariz., July 07, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, closed the sale of 31 corporate owned and managed clinics and associated franchise licenses in Arizona and New Mexico to Joint Ventures, LLC in exchange for $8.3 million in cash and the regional developer (RD) territory rights of the Northwest region that generated $855,000 in royalties and franchise fees over the 12 months ended March 31, 2025.
“Our goal for the refranchising initiative is to strengthen and simplify our business, while ensuring our clinics go to proven franchise operators that can improve performance and grow within their regions,” said The Joint Corp.’s President, Chief Executive Officer and Director Sanjiv Razdan. “We are very happy that Joint Ventures, one of our strongest franchisees, is purchasing 31 clinics in Arizona and New Mexico. As part of the consideration for the clinics, we are acquiring Joint Ventures' regional developer rights for the Northwest region, covering 46 existing franchised clinics and 30 sites for future clinic development. By acquiring RD rights, we will reduce commission obligations and increase operating margin, as these clinics incurred $855,000 in royalties and commissions under these RD rights in the trailing twelve months ended March 31, 2025. By increasing their stake in The Joint, existing franchisees are validating our initiatives to strengthen the patient experience, drive revenue and reduce operational costs. We expect to deploy our expanding working capital to generate value for stockholders.”
Forward-Looking Statements
This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Words such as, “anticipates,” “believes,” “continues,” “estimates,” “expects,” “goal,” “objectives,” “intends,” “may,” “opportunity,” “plans,” “potential,” “near-term,” “long-term,” “projections,” “assumptions,” “projects,” “guidance,” “forecasts,” “outlook,” “target,” “trends,” “should,” “could,” “would,” “will,” and similar expressions are intended to identify such forward-looking statements. Specific forward-looking statements made in this press release include, among others, our goal for the refranchising initiative to strengthen and simplify our business, while ensuring our clinics go to proven franchise operators that can improve performance and grow within their regions; our belief that by increasing their stake in The Joint, existing franchisees are validating our initiatives to strengthen the patient experience, drive revenue and reduce operational costs; our belief that by acquiring RD rights, we will reduce commission obligations, increase operating margin; and our expectation to deploy our expanding working capital to generate value for stockholders. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, which has increased our costs and which could otherwise negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and other factors described in our filings with the SEC, including in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 14, 2025 and subsequently filed current and quarterly reports. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.
About The Joint Corp. (NASDAQ: JYNT)
The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to
Franchise Times’
annual “Top 400” and “Fast & Serious” list of 40 smartest growing brands.
Entrepreneur
named The Joint “No. 1 in Chiropractic Services,” and is regularly ranked on the publication’s “Franchise 500,” the “Fastest-Growing Franchises,” the “Best of the Best” lists, as well as its “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners.”
SUCCESS
named the company as one of the “Top 50 Franchises” in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit
www.thejoint.com
. To learn about franchise opportunities, visit
www.thejointfranchise.com
.
The Joint Business Structure
The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Washington, West Virginia and Wyoming, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.
Media Contact:
Margie Wojciechowski, The Joint Corp.,
[email protected]
Investor Contact:
Kirsten Chapman, Alliance Advisors IR, 415-433-3777,
[email protected]